
Govt Bans Pharma Reps in Govt Hospitals | Big Move to Stop Prescription Bias | Health Ministry Orders
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
In a landmark decision, the Union Health Ministry has officially banned pharmaceutical sales representatives from visiting doctors inside government hospitals during duty hours. This directive applies to all central and state-run public hospitals across India.
Why this ban?
To curb the growing commercial influence on medical prescriptions and protect ethical healthcare practices. The new policy ensures that all communication from pharma companies must go through official channels like hospital procurement committees — promoting transparency and patient-first care.
Key Highlights:
Ban on medical reps inside government hospitals
Doctors cannot meet sales reps during duty hours
Pharma companies to use official hospital channels
Hospitals must enforce the ban strictly
Disciplinary action for violations
This move is expected to reduce prescription bias, improve public healthcare transparency, and rebuild trust in India’s medical system.
Subscribe for more healthcare updates and policy changes in India.
Youtube : https://youtube.com/shorts/_q-5qfY-_xw?feature=share
WEBSITE : https://medgatetoday.com/